REELIN INFLUENCES THE EXPRESSION AND FUNCTION OF DOPAMINE D2 AND SEROTONIN 5-HT2A RECEPTORS: A COMPARATIVE STUDY

被引:11
作者
Varela, M. J. [1 ]
Lage, S. [1 ]
Caruncho, H. J. [2 ]
Cadavid, M. I. [1 ]
Loza, M. I. [1 ]
Brea, J. [1 ]
机构
[1] Univ Santiago de Compostela, Ctr Invest Med Mol & Enfermedades Cron CIMUS, BioFarma Res Grp, Santiago De Compostela 15782, Spain
[2] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
reelin; heterozygous reeler mice; striatum; frontal ortex; GPCRs; schizophrenia; PUTATIVE VULNERABILITY FACTOR; FRONTAL-CORTEX; DOWN-REGULATION; MESSENGER-RNA; BIPOLAR DISORDER; DENDRITIC SPINE; SCHIZOPHRENIA; BRAIN; MICE; POSTMORTEM;
D O I
10.1016/j.neuroscience.2015.01.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reelin is an extracellular matrix protein that plays a critical role in neuronal guidance during brain neurodevelopment and in synaptic plasticity in adults and has been associated with schizophrenia. Reelin mRNA and protein levels are reduced in various structures of post-mortem schizophrenic brains, in a similar way to those found in heterozygous reeler mice (HRM). Reelin is involved in protein expression in dendritic spines that are the major location where synaptic connections are established. Thus, we hypothesized that a genetic deficit in reelin would affect the expression and function of dopamine D2 and serotonin 5-HT2A receptors that are associated with the action of current antipsychotic drugs. In this study, D2 and 5-HT2A receptor expression and function were quantitated by using radioligand binding studies in the frontal cortex and striatum of HRM and wild-type mice (WTM). We observed increased expression (p < 0.05) in striatum membranes and decreased expression (p < 0.05) in frontal cortex membranes for both dopamine D2 and serotonin 5-HT2A receptors from HRM compared to WTM. Our results show parallel alterations of D2 and 5-HT2A receptors that are compatible with a possible hetero-oligomeric nature of these receptors. These changes are similar to changes described in schizophrenic patients and provide further support for the suitability of using HRM as a model for studying this disease and the effects of antipsychotic drugs. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 56 条
[21]   Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder -: A postmortem brain study [J].
Guidotti, A ;
Auta, J ;
Davis, JM ;
Gerevini, VD ;
Dwivedi, Y ;
Grayson, DR ;
Impagnatiello, F ;
Pandey, G ;
Pesold, C ;
Sharma, R ;
Uzunov, D ;
Costa, E .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (11) :1061-1069
[22]   Neurobiology of dopamine in schizophrenia [J].
Guillin, Olivier ;
Abi-Dargham, Anissa ;
Laruelle, Marc .
INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 :1-+
[23]  
Hernandez I, 2000, J NEUROSCI RES, V59, P218, DOI 10.1002/(SICI)1097-4547(20000115)59:2<218::AID-JNR8>3.3.CO
[24]  
2-8
[25]   Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia [J].
Hurlemann, R ;
Boy, C ;
Meyer, PT ;
Scherk, H ;
Wagner, M ;
Herzog, H ;
Coenen, HH ;
Vogeley, K ;
Falkai, P ;
Zilles, K ;
Maier, W ;
Bauer, A .
ANATOMY AND EMBRYOLOGY, 2005, 210 (5-6) :519-523
[26]   A decrease of reelin expression as a putative vulnerability factor in schizophrenia [J].
Impagnatiello, F ;
Guidotti, AR ;
Pesold, C ;
Dwivedi, Y ;
Caruncho, H ;
Pisu, MG ;
Uzunov, DP ;
Smalheiser, NR ;
Davis, JM ;
Pandey, GN ;
Pappas, GD ;
Tueting, P ;
Sharma, RP ;
Costa, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15718-15723
[27]   SZGR: a comprehensive schizophrenia gene resource [J].
Jia, P. ;
Sun, J. ;
Guo, A. Y. ;
Zhao, Z. .
MOLECULAR PSYCHIATRY, 2010, 15 (05) :453-462
[28]   The Stanley Neuropathology Consortium Integrative Database: a Novel, Web-Based Tool for Exploring Neuropathological Markers in Psychiatric Disorders and the Biological Processes Associated with Abnormalities of Those Markers [J].
Kim, Sanghyeon ;
Webster, Maree J. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (02) :473-482
[29]   Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium [J].
Knable, MB ;
Barci, BM ;
Webster, MJ ;
Meador-Woodruff, J ;
Torrey, EF .
MOLECULAR PSYCHIATRY, 2004, 9 (06) :609-620
[30]  
LARUELLE M, 1993, ARCH GEN PSYCHIAT, V50, P810